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A B S T R A C T
Background
People requiring long-term bladder draining with an indwelling catheter can experience catheter blockage. Regimens involving different
solutions can be used to washout catheters with the aim of preventing blockage.
Objectives
To determine if certain washout regimens are better than others in terms of effectiveness, acceptability, complications, quality of life
and economics for the management of long-term indwelling urinary catheterisation in adults.
Search methods
We searched the Cochrane Incontinence Group Specialised Trials Register (searched 30 April 2009), MEDLINE (January 1966 to
April 2009), MEDLINE In-Process (30 April 2009), EMBASE (January 1980 to April 2009) and CINAHL (December 1981 to April
2009). Additionally, we examined all reference lists of identified trials and contacted manufacturers and researchers in the field.
Selection criteria
All randomised and quasi-randomised trials comparing catheter washout policies (e.g. washout versus no washout, different washout
solutions, frequency, duration, volume, concentration, method of administration) in adults (16 years and above) in any setting (i.e.
hospital, nursing/residential home, community) with an indwelling urethral or suprapubic catheter for more than 28 days.
Data collection and analysis
Data were extracted by three reviewers independently and compared. Disagreements were resolved by discussion. Data were processed
as described in the Cochrane Handbook. If the data in trials were not fully reported, clarification was sought from the authors. For
categorical outcomes, the numbers reporting an outcome were related to the numbers at risk in each group to derive an risk ratio (RR).
For continuous outcomes, means and standard deviations were used to derive weighted mean differences (WMD). No meta-analysis
of study results was possible.
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Main results
Five trials met the inclusion criteria involving 242 patients (132 completed) in two cross-over and three parallel-group randomised
controlled trials. Only three of the eight pre-stated comparisons were addressed in these trials. Some trials addressed more than one
comparison (e.g. washout versus no washout and one type of washout solution versus another). The analyses reported for the two cross-
over trials were inappropriate as they were based on differences between groups rather than differences within individuals receiving
sequential interventions. Two parallel-group trials had limited value: one combined results for suprapubic and urethral catheters and
one had data on only four participants. Only one trial was free of significant methodological limitations, but its sample size was small.
Three trials compared no washout with one or more washout solution (saline or acidic solutions) and authors tended to conclude
no difference in clinical outcomes between washout and no washout. In the one trial which had data of sufficient quality to allow
interpretation, no difference was detected between washout and no washout groups in the rate of symptomatic urinary tract infection
or time to first catheter change.
Three trials compared different types of solution: saline versus acidic solutions (two trials); saline versus acidic solution versus antibiotic
solution (one trial). Authors tended to report no difference between different washout solutions but the data were too few to support
their conclusions. The one trial which warranted consideration concluded no difference between saline and an acidic solution in terms
of symptomatic urinary tract infections or time to first catheter change.
Authors’ conclusions
The data from five trials comparing differing washout policies were sparse and trials were generally of poor quality or poorly reported.
The evidence was too scanty to conclude whether or not washouts were beneficial. In the first instance we require further rigorous, high
quality trials with adequate power to detect any benefit from washout being performed as opposed to none. Then trials comparing
different washout solutions, washout volumes, frequencies/timings and routes of administration are needed.
P L A I N L A N G U A G E S U M M A R Y
Policies on flushing urinary catheters which are used on a long-term basis
Many people have incontinence (leak urine) or are unable to empty their bladder properly. Some can be helped by having a catheter
inserted into their bladder, through which urine is passed out of the body. When the catheter is kept in place on a long-term basis
blockages may occur. Liquid solutions may be injected into the catheter to prevent or relieve a blockage. This is sometimes known as a
washout. In this review we wished to assess how effective washouts were. We looked for studies which included people with long-term
catheters, where they were allocated at random to have catheter washouts or not, and the effects compared. Studies which compared
different types of washout solution were also searched for. Only five relevant studies were found. All five concluded that there was no
evidence that washouts were helpful. However most studies were small and of poor quality, and their results could not be combined.
We concluded that, at present, there is not enough good research evidence to say whether or not consumers and providers of health
care should use catheter washouts.
B A C K G R O U N D
Description of the condition
Indwelling catheterisation may be used for the management of
people with intractable incontinence or chronic obstruction. Peo-
ple may require long-term urinary catheterisation for a number
of reasons: urinary retention (incomplete emptying of the blad-
der) caused by benign prostatic hyperplasia (enlarged prostate) or
prostate tumour, or urinary incontinence (involuntary leakage of
urine) not amenable to toileting, intermittent catheterisation, or
any other method of management. Individuals with conditions
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such asmultiple sclerosis, dementia, stroke, spina bifida, and spinal
cord injury may be susceptible to these problems.
It is difficult to know precisely how many people are currently
managed with long-term catheters. Estimates vary from 4% to
28% of patients in long-term care facilities (Cools 1986; Kunin
1992; Ouslander 1985; Ouslander 1987; Warren 1989) and 4%
of patients living at home or in the community (Getliffe 1990; Roe
1989). Those using catheters long-term often experience compli-
cations such as blockage, leakage and infection. These complica-
tions can have significant implications for resource use and quality
of life due to increased general practitioner and hospital outpatient
appointments, emergency admissions and nursing time demands
(Evans 2000).
Bacterial Infection
At the root of catheter-associated complications is bacteriuria
which occurs when bacteria colonise the urinary tract. The risk of
acquiring bacteriuria increases with increasing days of catheteri-
sation (Garibaldi 1974; Stark 1984). High concentrations of bac-
teriuria were found in 98% of patients with long-term urinary
catheters (Warren 1982). Increased levels of bacteriuria expose pa-
tients to an increased risk of complications, including symptomatic
urinary tract infections (UTIs), secondary bacteraemia (infection
in the blood) and infection at other sites, such as the joints. Up to
30% of long-term catheterised people will become symptomatic
and require some intervention (Saint 1999). Catheter-associated
infection is therefore a significant problem in long-term care.
In an attempt to deal with the problem of bacterial colonisa-
tion, biofilm build-up and UTI, catheter washouts or irrigations
(sometimes called bladder washouts or irrigations) were intro-
duced (Getliffe 2003). Various antibiotic and antiseptic solutions
have been used as washouts over the last few decades with the aim
of preventing and treating these catheter-associated problems. Ev-
idence with regard to their effectiveness in this respect however
is conflicting. There is also concern that their use can damage
the bladder mucosa and increase infection rates due to opening
the closed system. Current UK National Health Service guide-
lines specify that antibiotic solutions are not effective in treat-
ing catheter-associated UTIs (NHS QIS 2004). Use of antiseptic
washouts is also believed to be of little value for the prevention and
treatment of catheter-associated UTI and is therefore no longer
advised in practice (Pellowe 2003).
Catheter Blockage
The most common problem of long-term indwelling catheters is
the formation of encrustations on the surface of the catheter with
consequent blockage and by-passing of urine resulting in urinary
leakage. Nearly half of all individuals with an indwelling catheter
will experience problems with catheter blockage due to encrus-
tation (Getliffe 1992; Kohler-Ockmore 1996; Kunin 1987; Roe
1987). Blockage of an indwelling catheter is traumatic for both
patients and their carers as it often causes pain and distress. Much
research has been done showing that encrustation is caused by in-
fection of the urine by bacteria which produce the enzyme ure-
ase, e.g. Proteus mirabilis, Pseudomonas aeruginosa and Klebsiella
species. Urease breaks down urea to form ammonia which results
in an increase in the alkalinity of the urine. Under these condi-
tions, mineral salts such as calcium phosphate and magnesium
ammonium phosphate (struvite) are deposited onto the catheter
surface causing encrustation (Hesse 1992).
Fungal Infection
Candiduria (the presence of candida organisms in the urine) can
also occur in individuals with long-term indwelling catheters, and
its incidence is directly related to duration of catheterisation, hos-
pitalisation, and antibiotic use (Hamory 1978). It is generally
asymptomatic but complications can include fungal balls in the
bladder or renal pelvis, renal infection and disseminated candidi-
asis (infection with a species of candida). Management of asymp-
tomatic catheter-associated candiduria is unclear. Removal of the
catheter results in the disappearance of candiduria in about one
third of patients. For asymptomatic individuals whose candiduria
persists or who must remain catheterised, several management
techniques have been used, primarily involving oral medication or
bladder irrigation. The solutions used, the method of administra-
tion (continuous irrigation), and the primary outcomes of inter-
est (e.g. death, length of hospitalisation, invasive infection) in the
treatment of fungal infections are very different, however, to those
used to administer solutions for bacterial infection and catheter
blockage, and hence are not evaluated in this review.
Description of the intervention
Current practice in the management of catheter encrustation and
blockage varies but is largely dependent on the use of catheter
maintenance solutions. Treatments commonly used in commu-
nity-dwelling patients include washing out the catheter with saline
and acidic solutions. There is much debate however about this
particular practice. In vitro evidence suggests that normal saline is
ineffective in diminishing encrustations whereas there is some evi-
dence that methenamine preparations and acidic washouts reduce
catheter encrustation (Getliffe 1994; Hesse 1989; King 1991).
Other work however questions the efficacy of acidification of the
urine for preventing catheter encrustation (Bibby 1993). In a study
by Capewell and Morris none of the continence advisers ques-
tioned thought that regular washouts were useful compared to
25% of district nurses who thought they were (Capewell 1993).
Despite the controversy surrounding the effectiveness of washouts
for managing encrustation and blockage, a recent study has shown
that they are widely used (Pomfret 2004).
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Why it is important to do this review
In summary, there is no consensus regarding the indications for use
of catheter washouts nor themethod of administration, frequency,
duration of administration and choice of solution. The wide vari-
ety of solutions available, combined with the multiplicity of pos-
sible procedures for applying these, and the potential risks they
pose indicated that a systematic review of the evidence regarding
washout policies may have important implications for both clin-
ical practice and future research. This review aims to summarise
the evidence from randomised controlled trials related to the use
of catheter washouts for the management of long-term indwelling
urinary catheterisation in adults. The results from this review will
highlight gaps in the evidence base and assist in the identification
of best practice.
O B J E C T I V E S
The purpose of this review was to determine if certain washout
regimens are better than others in terms of effectiveness, accept-
ability, complications, quality of life and economics for the man-
agement of long-term indwelling urinary catheters in adults.
The following comparisons were made:
1) using any type of catheter washout (e.g. water, saline, antiseptic,
antibiotic) versus not using one;
2) one type of catheter washout solution versus another type;
3) clinically or microbiologically indicated washout versus routine
washout;
4) long intervals between catheter washouts versus short intervals;
5) one method of administration of catheter washouts (e.g. agita-
tion, gravity, syringe) versus another method;
6) smaller volumes of washout solution versus larger volumes;
7) a stronger solution of washout versus a weaker solution;
8) a single washout instillation versus two or more sequential
washout instillations of the same type.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised or quasi-randomised controlled trials, including
cross-over designs, evaluating the use of urinary catheter washouts
in long-term catheterised adults.
Types of participants
Adults, at least sixteen years of age, in any setting (i.e. hospital,
nursing/residential home, community) with an indwelling ure-
thral, suprapubic or perineal catheter in-situ for more than 28
days. Adults who combine intermittent catheterisation with peri-
ods of indwelling catheterisation were only included if they had
had an indwelling catheter in-situ for more than 28 days at the
time of data collection.
Types of interventions
The interventions considered included catheter washouts with wa-
ter, saline, antiseptic, acidic or antibiotic solutions or any combina-
tion of these. Studies were considered that compared (1) washouts
with controls who did not receive washouts, (2) washouts with
other participants who received different washouts, (3) different
washout regimens at different time periods i.e. cross-over studies,
and (4) different washout regimens i.e. frequency, duration, vol-
ume, concentration, method of administration.
Throughout the literature, the terminology used to refer to
the ’washing-out’ of catheters is somewhat confusing. The term
’washout’ tends to be used in the US literature whereas in the
UK, catheter washouts are often referred to as ’catheter mainte-
nance solutions’ or ’bladder washout’ which can cause confusion
with bladder irrigation/lavage used after surgery (Getliffe 1996).
Throughout this review all trials referring to catheter or bladder
washouts were consideredwith the exception of post-surgical blad-
der irrigations, therapeutic bladder instillations used, for example,
in the treatment of cancer patients, and continuous irrigations
with antifungal solutions.
Trials that involved irrigation of catheter drainage bags were not
considered in this review. Other types of interventions to prevent
or reduce encrustation or infection e.g. changes in fluid intake or
use of oral prophylactic antibiotics, were also excluded.
Types of outcome measures
Primary outcomes
Catheter washouts were originally introduced to prevent or reduce
the occurrence of catheter-associated infection. In recent years
their use has been primarily aimed at minimising the effects of re-
current encrustation and blockage. Primary outcomes considered
were therefore objective measures of catheter-associated UTI and
catheter blockage. Such measures include:
• rates of asymptomatic bacteriuria,
• symptomatic UTIs,
• number of catheters used,
• length of time each catheter was in situ, and
• catheter removal rates due to blockage/ infection
(definitions of blockage/ infection will be those used in the trial
reports).
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Trials were considered if they reported at least one of these primary
outcomes.
Secondary outcomes
Where reported, the following outcomes were also recorded:
1. Washout acceptability measures
This includes levels of patient discomfort associated with
washouts; patient satisfaction with the outcome of washouts
(i.e. minimisation of catheter-associated problems, reduction in
pain and trauma when catheter withdrawn); and ease of use of
washouts/washout regimens for patients, their carers and practi-
tioners.
2. Health status or measures of psychological health
This includes quality of life and psychological outcome indicators
as measured by generic validated instruments e.g. Short Form 36
(Ware 1993), Hospital Anxiety and Depression Score (HADS)
(Zigmond 1983).
3. Measures of complications/adverse effects of washouts
This includes adverse effects that result at the time of administra-
tion of washouts, such as inability to tolerate washout solution,
and irritation or trauma to urethral or bladder tissue. These effects
may be indicated by bypassing or bleeding around the catheter or
by volume of red blood cells returned during washout procedure.
Use of prophylactic antibiotics and rescue antibiotics are also in-
cluded.
4. Health economic outcomes
Economic measures considered include costs of washouts, re-
source implications associated with different washouts/washout
regimens, and any reports of formal economic evaluations of
washouts, such as cost-effectiveness or cost-utility analysis.
Any other non-pre-specified outcomes, judged to be important
when performing the review, were considered.
Search methods for identification of studies
We did not impose any language or other limitations on any of
the searches described below.
Electronic searches
This review has drawn on the search strategy developed for
the Cochrane Incontinence Review Group. Relevant trials were
identified from the Group’s Specialised Register of controlled
trials which is described, along with the search strategy, un-
der the Incontinence Group’s details in The Cochrane Li-
brary (For more details of the search methods used to build the
Specialised Register please see the ‘Specialized Register’ section
of the Group’s module in The Cochrane Library). The register
contains incontinence-related trials identified from MEDLINE,
CINAHL, the Cochrane Central Register of Controlled Trials
(CENTRAL) and handsearching of journals and conference pro-
ceedings. The trials in the Incontinence Group Specialised Regis-
ter are also contained in CENTRAL. The date of the most recent
search of the Incontinence Group’s Specialised Register for this
review was 30 April 2009.
The Incontinence Group Specialised Register was searched using





(All searches were of the keyword field of Reference Manager 9.5
N, ISI ResearchSoft).
For this review specific extra searches were performed by the review
authors. These are detailed below:
We searched MEDLINE (January 1966 to April 2009), MED-
LINE In-Process (searched on 30 April 2009), EMBASE (Jan-
uary 1980 to Week 17 2009) was searched on 27 April 2009,
CINAHL on OVID (1982 to July Week 1 2007) was searched on
18 July 2007, CINAHL on EBSCO (December 1981 to Week 4
April 2009) was searched on 28 April 2009. These databases were
searched using appropriate free text and MeSH terms/EMTREE
terms/controlled vocabulary. This was done by adapting terms
drawn from the existing search strategies of the Incontinence
Review Group to meet the objectives of this review. The UK
National Research Register, Controlled Clinical Trials and ZE-
TOC database of conference abstracts were searched on 17 Oc-
tober 2006. Full details of the search strategies used are given in
Appendix 1.
Searching other resources
We searched the reference lists of relevant articles for other possi-
bly relevant trials. Key researchers in the field of catheter manage-
ment, and catheter maintenance solution manufacturers (BBraun,
Coloplast and Bard) were contacted to identify other possibly rel-
evant trials.
We placed calls for information about other possibly relevant trials
on the Association for Continence Advice (ACA) website (March
2007), the ACA quarterly Journal (Volume 26 Issue 2 2007),
and the weekly Update of Royal College of Nursing Research &
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Development Co-ordinating Centre electronic bulletin (W/C 26
March 2007). Presentations were given at the 2007 RCN Interna-
tional Nursing Research Conference (April 2007), the 22nd An-
nual Scottish Task Force Symposiumon Incontinence (May 2007)
and the ScottishNMAHPResearch into Practice Conference (Oc-
tober 2007) to inform others of this review and invite information
on other possibly relevant studies.
Data collection and analysis
Selection of studies
Two reviewers (LS and SC) independently assessed all titles and ab-
stracts of studies identified from the above search strategy. Where
there was any doubt regarding the potential eligibility of a study,
the full paper was obtained. Any disagreements with regard to the
eligibility of a study were resolved by discussion between the two
reviewers. Any disagreements that could not be resolved by dis-
cussion were resolved by consultation with a third reviewer (SH).
Studies were excluded from the review if theywere not randomised
or quasi-randomised trials of catheter washouts for adults with
long-term indwelling urinary catheters, or if they made compar-
isons other than those pre-specified. Excluded studies are listed
with reasons for their exclusion (see table of Excluded Studies).
Data extraction and management
Data extraction was performed independently by the review au-
thors (LS, SC and SH), using a data collection form purposively
designed for the review, and comparisons made to ensure accuracy.
Any discrepancies were discussed until agreement was reached. At-
tempts were made to contact authors of trial reports if data were
missing or not fully reported, or if clarification was necessary.
Assessment of risk of bias in included studies
Each of the eligible trials were critically appraised and themethod-
ological quality assessed independently by three review authors
(LS, SC and SH), without prior consideration of the results. The
assessment tool for risk of bias used in The Cochrane Collabora-
tion was implemented. This was used to assess risk of bias in four
domains (sequence generation, allocation concealment, blinding
(participants, personnel and outcome assessors) and incomplete
outcome data), and included criteria for judging studies to be at
high or low risk of bias. A risk of bias table for each study was
included in the Characteristics of included studies table.
Data synthesis
Included trial data were processed as described in the Cochrane
Handbook for Systematic Reviews of Interventions (Deeks 2008).
Where appropriate, meta-analysis were undertaken. For binary
outcomes, the numbers reporting an outcome were related to the
numbers at risk in each group to derive an risk ratio (RR). For
continuous outcomes, means and standard deviations were used
to derive weighted mean differences (WMD). For cross-over trials
the data were analysed as recommended in section 16.4 of the
handbook, subject to the availability of suitable data.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Results of the search
Approximately 700 papers were identified from the above search
strategy. Twenty of these reported potentially eligible studies and
were therefore given particular consideration. Clarification was
sought at this stage regarding study characteristics from four au-
thors: one author responded, two authors were unable to be con-
tacted and no response was received from one author. Fourteen
of the 20 studies were subsequently excluded from the review and
descriptions of these are given in the table of Characteristics of Ex-
cluded Studies (Andersson 1986; Bach 1990; Bruun 1978; Davies
1987; Elliott 1989; Elliott 1990; Furuno 1998; Gelman 1980;
Kennedy 1984; Meyers 1964; Robertson 1990; Ruwaldt 1983;
Vainrub 1977;Warren 1978). One study (Airaksinen 1979), writ-
ten in Finnish, is awaiting fuller translation.
Therefore five studies were included in the review. Three of these
were parallel-group randomised controlled trials and included a
total of 173 participants (McNicoll 2003; Moore 2009; Waites
2006) and two were randomised cross-over trials that included
a total of 69 participants (Kennedy 1992; Muncie 1989). Two
studies were conducted in the UK (Kennedy 1992; McNicoll




Kennedy 1992 studied 25 elderly catheterised females in long-
term geriatric care. No exclusion criteria were stated explicitly. The
mean age of participants was 82 years (range 65 to 100 years). The
type of catheter used was that already in use by the participant.
McNicoll 2003 studied 11 community patients with long-term
catheters known to block with encrustation. No exclusion criteria
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were stated. There was no information about the age or gender of
the participants, what type of catheter they had or how long it had
been in situ.
Moore 2009 studied 73 community-dwelling or long-term care
adults (36 males, 37 females) with long-term indwelling catheters
that required changing every three weeks or less, requiring sup-
portive or continuing care. Excludedwere those with symptomatic
UTI, although individuals were eligible after 14 symptom-free
days following treatment. Further exclusion criteria included:
urethral erosion allowing continuous bypassing around urinary
catheter; history of bladder cancer, radiation or interstitial cysti-
tis; impaired renal function as evidenced by a serum creatinine
level of 2.0 mg/dL or higher; or gross haematuria. The mean age
of participants was 66.2 years (SD 17.64). A hydrophilic coated
catheter (Bard) was used for all patients in this trial.
Muncie 1989 studied 44 long-term hospitalised female patients
at one centre, aged 18 years or more who had indwelling urethral
catheters in place for 30 consecutive days or longer, were afebrile
(temperature ≤ 37.7 degrees) for seven days and had not received
antibiotics for 14 days. Patients withmalignant bladder neoplasms
or those requiring continuedbladder irrigationwere excluded.The
mean age of participants was 71 years (range 37 to 88 years). The
study catheter was an 18 F, silicone-coated latex urethral catheter.
Waites 2006 randomised 89 community-residing patients (49
male, 40 female) with neurogenic bladder managed by indwelling
catheter (71 Foley catheter, 18 suprapubic tube; material not
stated). All were at least six months post spinal cord injury or on-
set of other neurological disease and had evidence of microscopic
bacteriuria and pyuria at time of study enrolment. Excluded were:
people with seriousUTIs requiring systemic antibiotics; those with
prior renal function abnormalities; those who had used an acidi-
fying agent, bladder irrigant or systematic antibiotic in the previ-
ous seven days; and those who were pregnant or unable/unwilling
to give informed consent. The mean age of participants was 45.8
years (range 19 to 82 years). The catheter material, and duration
that the catheter was in situ pre-study enrolment, were not stated.
There were no differences in demographic or injury-related vari-
ables by group at baseline.
Interventions
Two trials compared washout (using saline and/or acidic solution)
with no washout (Moore 2009; Muncie 1989). Two trials com-
pared different types of washout solution (Kennedy 1992; Waites
2006), one of which included a comparison of alternative com-
positions of an acidic solution (Kennedy 1992). The remaining
trial compared washout with planned catheter removal (McNicoll
2003). The protocol for the planned catheter removal group was
not described however, and in fact varied from patient to pa-
tient. Thus it is included in this review only with trials comparing
washout versus no washout.
Washout versus no washout:
In Moore 2009 participants were randomised to one of three
groups: 1) a usual care group with no washout, 2) a group with
weekly catheter washout with 50 ml sterile normal saline, 3) a
catheter washout weekly with 50 ml sterile Contisol (also known
as Suby G) (citric acid 3.23%, light magnesium oxide 0.38%,
sodium bicarbonate 0.7%, and disodium edetate 0.01%). A study
catheter was inserted for all individuals at the start of the study. For
participants in the washout groups, prior to washout the catheter
was clamped, disconnected, and both the drainage tube and the
catheter end were wiped with an alcohol swab. The nozzle of the
washout container was inserted into the catheter and the contents
were gently squeezed by pressing on the base, providing a con-
trolled flow over 60 seconds. The bellows of the container were
then allowed to slowly reinflate, and the flushing action was re-
peated five times. The solution was retained in the bladder for 15
minutes and then released. The intervention duration was eight
weeks.
Muncie 1989 compared 1) 10 weeks of once daily normal saline
washout (30 ml via syringe) with 2) 10 weeks of no washout. New
catheters were inserted at the beginning and end of each study
phase, and drainage bags were changed weekly in both groups.
The drainage bags used had built-in irrigation ports to enabled
washout without disruption of the closed catheter system. The
intervention duration was 24 weeks (two-week no washout run-
in period, 10-week washout or no washout phase, and two-week
no intervention period before entering alternate phase).
The McNicoll trial (McNicoll 2003) had two parallel groups: 1)
daily instillation of citric acid catheter maintenance solution, and
2) planned catheter removal. The volume of solution and method
of administration in the washout group were not stated. The con-
trol group were to receive “planned catheter changes ” but the
protocol was not described and in reality this varied from patient
to patient. The intervention duration was 12 weeks.
Different types of solution:
Three types of solution were evaluated in the Kennedy trial
(Kennedy 1992): 1) three weeks of twice weekly washout with
0.9% sodium chloride (saline), 2) three weeks of twice weekly
washout with Suby G (as described above), 3) three weeks of
twice weekly washout with Solution R (citric acid 6%, glucono-
lactone 0.6%, light magnesium carbonate 2.8%, disodium ede-
tate 0.01%). All washouts were administered by attaching a 100ml
sterile, pre-packed sachet to the catheter and allowing it to drain
into the bladder via gravity. The catheter was clamped for 20 to
30 minutes and then the fluid was allowed to drain out. Catheters
were changed at weeks 1, 5, 9 and 12. Random number tables
were used to decide the order in which the three solutions were
administered. The intervention duration was 12 weeks (one-week
normal saline washout run-in period, plus a three-week phase with
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each of the solutions, and one week normal saline washout be-
tween solutions).
Waites 2006 compared three solutions: 1) eight weeks of twice
daily normal saline washout, 2) eight weeks of twice daily 0.25%
acetic acid washout, 3) eight weeks of twice daily neomycin-
polymyxin GU washout (containing 40mg/ml neomycin sulfate
and 200,000 units/ml polymyxin B). At each time of washout 30
ml of the irrigant was instilled for 20 minutes via a syringe.
As described above, the Moore 2009 trial had three arms and
provided, in addition to a washout versus no washout comparison,
a comparison of saline and Contisol washout solutions.
A stronger solution of washout is better than a weaker
solution:
As described above, within theKennedy trial (Kennedy 1992), two
groups received washouts with different compositions of acidic
solution: one solution contained 3.23% citric acid (Suby G) and
the other 6% citric acid (Solution R). However other chemical
components of the two solutions differed also.
Outcomes
All trials except one (McNicoll 2003) reported data on bacteriuria
or symptomaticUTI. All trials except one (Waites 2006) presented
data on removal/replacement of catheters, either reporting mean
number of days a catheter was in situ (Kennedy 1992; Moore
2009) or mean number of replacements (McNicoll 2003; Muncie
1989). Kennedy 1992 and Moore 2009 looked specifically at the
problem of catheter encrustation. Moore 2009 and Waites 2006
measured urine pH. Three trials reported data on complications
or adverse events, one in terms of red blood or urothelial cells in
the washout fluid (Kennedy 1992), one in terms of incidence of
microscopic haematuria and leukocytes in pre-washout dipstick
urinalysis (Moore 2009), and one in terms of bladder spasms due
to the washout procedure (Waites 2006).Only one trial (McNicoll
2003) considered the economic outcomes, reporting on the cost
of the interventions and the time involved in administering them.
Risk of bias in included studies
All but one of the trials had at least one factor associated with risk
of bias (Figure 1; Figure 2).
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
Allocation
Little information was provided regarding the process of conceal-
ment of group allocation within most of the trials. In Kennedy
1992 it was assumed the allocation process was not concealed as
random number tables were used to determine the order in which
patients received the three solutions. It was stated in McNicoll
2003, Muncie 1989 and Waites 2006 that there was random allo-
cation to groups but no details were given. In Moore 2009 group
assignment was determined by a computer-generated list of ran-
dom numbers, placed in opaque envelopes, which were opened by
the participant after consent was obtained.
Blinding
Most studies gave insufficient or no information relating to blind-
ing. This may have been because blinding in this area of research is
difficult e.g. patients and health care providers are obviously aware
of bladder washout being performed, and different washout solu-
tions may look different and so can be identified. There was no
detail in Kennedy 1992, McNicoll 2003 or Muncie 1989 regard-
ing blinding of the participants, health care providers or outcome
assessors as to the intervention being given. Moore 2009 acknowl-
edged that it was not possible to blind the research nurse to the
two washout solutions due to the nature of the packaging. The
outcome assessor was the nurse performing the washout who was
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therefore not blinded. It was stated in Waites 2006 that partici-
pants and health care providers were blinded to treatment status
but no description of this was given.
Incomplete outcome data
All included trials experienced significant withdrawals and drop-
outs, resulting in incomplete outcome data, however this was well
described. Two trials (Muncie 1989; Waites 2006) explored dif-
ferences between completers and non-completers. The two small
trials (Kennedy 1992;McNicoll 2003) suffered serious loss of par-
ticipants leaving few data for analysis (n=14 and n=4 respectively),
compared with larger analysis datasets of the other trials (Moore
2009 n=53, Muncie 1989 n=32, Waites 2006 n=52).
• Of the 25 patients who entered the Kennedy 1992 trial, five
died, three had their catheters removed, two withdrew at the
request of nursing staff and one was discharged home and lost to
follow-up, leaving 14 patients (56%) who completed the full 12
weeks of the trial.
• Of the 11 participants enrolled in the McNicoll 2003 trial,
seven were lost to follow-up for reasons not stated and thus only
four participants’ data (34%) were analysed (citric acid group n=
1, planned catheter change group n=3).
• Fifty-three out of 73 participants (73%) completed all eight
weeks of the study protocol in Moore 2009 (no washout n=20,
saline n=16, Contisol n=17). Sixteen subjects terminated early
because of three catheter changes or self-reported UTI (non-
symptomatic). The remaining subjects (n=4) terminated before
completing eight weeks for other reasons: haematuria, latex
sensitivity, deceased/severe illness, or personal choice.
• Of the 44 women who entered the Muncie 1989 trial, 23
(52%) completed the full 24-week intervention. Of the 21 who
did not complete, nine women completed at least one phase and
five weeks of the second phase of the study. Thus data were
analysed on 32 participants (73%) (23 cross-overs, nine partial
cross-overs). Mean hospital stay was significantly longer in those
who completed the study compared to those who did not.
• Of the 89 participants enrolled in Waites 2006, 37
participants did not complete the full intervention (11 withdrew
due to development of symptomatic UTI, 14 withdrew for other
health-related reasons, 12 withdrew due to perceived difficulty,
inconvenience or unwillingness to perform twice daily washouts)
. Thus 52 participants (58%) completed the intervention (saline
n=21, citric acid solution n=9, antibiotic solution n=22). Years
since injury or onset of disease was significantly greater for
participants who did not complete the trial protocol.
Other potential sources of bias
Only one trial (Moore 2009) stated that data were analysed us-
ing an intention-to-treat analysis. In this trial, for the purposes of
analysis, for withdrawn participants the primary outcome mea-
sure (the time to first catheter change) was taken as the date they
withdrew from the study. The remaining trials either did not anal-
yse using the intention to treat principle (McNicoll 2003; Muncie
1989; Waites 2006) or it was not clear if they did so (Kennedy
1992).
Effects of interventions
The purpose of this reviewwas to determine if certainwashout reg-
imens were better than others, and eight comparisons which po-
tentially could be addressed within the review were pre-specified.
Trials addressing three of these comparisons were found, involving
242 patients (132 completed) in two cross-over and three parallel-
group randomised controlled trials. Some trials addressed more
than one hypothesis. Three trials provided data on the comparison
between washout and no washout (McNicoll 2003; Moore 2009;
Muncie 1989) (Comparison 1). Three trials compared different
types of solution (Kennedy 1992; Moore 2009; Waites 2006)
(Comparison 2). In their trial comparing three washout solutions
Kennedy 1992 compared one acidic solution (Solution R, con-
tained 6% citric acid) with another of an alternative composition
(Suby G, contained 3.23% citric acid) (Comparison 7). McNicoll
2003 compared a washout with planned catheter change, a hy-
pothesis that hadnot beenpre-specified. For the purposes of this re-
view this trial has been grouped with the trials comparing washout
with no washout.
Only limited data were available in a form that allowed entry into
the tables of Comparisons and Data and corresponding meta-
analysis. No data were entered from four trials (Kennedy 1992;
McNicoll 2003;Muncie 1989,Waites 2006). Two of these studies
(Kennedy 1992 and Muncie 1989) were cross-over trials which
did not present data in a way that highlighted the paired nature of
the data, thus assessment was problematic. Data from only four
participants was reported in McNicoll 2003. The Waites 2006
trial combined outcome data for participants with urethral and
suprapubic catheters whichmade clinically-relevant interpretation
difficult.
The trials generally had small sample sizes, ranging from 25 to
89, although the number of participants that completed were far
fewer, ranging from 4 to 53. The authors of the largest trial (Moore
2009) (n=73; n=53 completed) proposed, based on their data, that
a trial with at least 400 participants per arm would be required
to give adequate power to detect a 20% difference in time to first
catheter change.
1) Using any type of catheter washout versus not
using one
Three trials addressed this comparison (McNicoll 2003; Moore
2009; Muncie 1989).
Bacteriuria
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Given that catheter obstructions may be related to particular bac-
terial species, Muncie 1989 reported for each group the mean
number of species at >=105 CFU/ml per urine specimen among
23 patients completing the cross-over trial (urine specimens were
obtained for culture every two weeks): for the saline washout pe-
riods the mean was 4.0, for the no washout periods the mean was
3.8. No test of statistical difference was reported. The four most
prevalent organisms were Providencia stuartii, Escherichia coli, P
mirabilis and Enterococcus. The percentage of specimens in which
each strain was present was said to be similar in the saline washout
and no washout periods of the study.
Symptomatic UTI
Muncie 1989 looked also at febrile episodes of possible urinary
origin as an indicator of symptomatic UTI. Data were reported
for all 32 patients (including those who did not complete the
trial) for combined phases of this cross-over trial. The mean num-
ber of febrile episodes of possible urinary origin per 100 days of
catheterisation for the three periods was reported: mean for the
saline washout period was 1.2 (SD 1.3), and for the no washout
period was 0.9 (SD 1.1). The authors reported the difference was
not statistically significant, although no details were given. Moore
2009 reported no symptomatic UTIs in any of the study partic-
ipants in the washout or non-washout groups (Analysis 1.1). A
symptomatic UTI was defined as having at least one of five indi-
cations: fever, urgency, dysuria or suprapubic tenderness, haema-
turia or positive urine culture. Self-reported UTIs (which did not
meet the study criteria for symptomatic UTI) were noted in each
group (citric acid 5/24, saline 2/18, no washout 3/23).
Catheter replacement
Themean catheter replacement rate per 100days of catheterisation
was reported in the trial by Muncie 1989: for the saline washout
periods the mean was 5.5 (n=32), for the no washout periods the
mean was 4.7 (n=32). Muncie 1989 also reported for each period
(saline washout/no washout) the numbers of catheters 1) replaced
due to obstruction (39/32); 2) replaced due to leakage (11/21);
and 3) removed outwith the study protocol (87/63). The authors
concluded that daily saline washouts had no significant effect on
the incidence of total number of catheter replacements. No details
of statistical tests were presented. McNicoll 2003 reported on the
mean number of catheter replacements during a 12 week period:
the citric acid washout group mean was 9 (SD 0) (n=1), the no-
washout group mean was 14.3 (SD 11.2) (n=3). Moore 2009
recorded the number of weeks until first catheter change within
the trial and reported no significant differences in the mean time
between the three groups: citric acid 4.57 (SD 2.61) (n=19), saline
5.18 (SD 2.90) (n=16), no washout 4.55 (SD 2.91) (n=20) (
Analysis 1.2).
Complications/adverse events
No data were reported.
Resources/costs
McNicoll 2003 found, in one participant in the intervention
group, that 37.25 hours were spent administering the washouts
over the 12 week period. They reported that care for the “planned
catheter change” group took less time, but no comparison data
were presented. The cost of the intervention was £975.51 for the
participant in the washout group compared to a mean of £188.70
(SD £102.90) per person for the cost of care in the control group.
2) One type of catheter washout solution versus
another type
Three trials addressed this comparison (Kennedy 1992; Moore
2009; Waites 2006).
Bacteriuria
In the cross-over trial byKennedy1992 comparing three solutions,
the percentage of patients with bacteria observed in washout fluid
at the end of a washout period with one of the trial solutions was
as follows: saline 100%, Suby G 75%, Solution R 76%. Only per-
centages were presented and it was unclear what the denominators
for these percentages were. The presence of bacteria was measured
also in 66 urine specimens collected from 25 patients at the time
of catheter change, and only four samples showed no significant
growth of bacteria (four after antibiotic treatment and one after
saline washouts), thus it was concluded that none of the solutions
being tested eliminated bacteria. The authors stated that the Suby
G and Solution R appeared to reduce the level of bacteria but that
the difference between solutions was not statistically significant
(no statistical test results were presented). It was concluded that
treatment with acidic solutions (i.e. Suby G and Solution R) did
not prevent or reduce urease-producer bacteria.
The published data on presence of bacteria were inadequately re-
ported. The percentages of participants harbouring Enterococcus
species (alone or in conjunction with other types of bacteria) af-
ter completing the Waites 2006 trial were as follows: saline 13/21
(62%), acetic acid 7/9 (87%), neomycin-polymyxin 19/22 (86%).
No test of significant difference between groups was presented. In
the antibiotic group, from study start to finish there was a signifi-
cant increase in the number of participants with enterococci bacte-
ria (p=0.02). Data were reported graphically and hence exact val-
ues were not available. The authors said they detected no advan-
tages of the antibiotic or acidic solutions over saline in reducing
the urinary bacterial load.
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Symptomatic UTI
The incidence of participants discontinuing the use of washouts
due to the development of a symptomatic UTI was reported by
Waites 2006: saline 1/29 (3%), acetic acid 6/30 (20%), neomycin-
polymyxin 4/30 (13%). The difference between groups was not
statistically significant. Overall a significantly greater proportion
of the acetic acid group participants discontinued, but this differ-
ence was due to more individuals in this group discontinuing for
“personal reasons unrelated to health”. As reported earlier, Moore
2009 found no symptomatic UTIs in any group in the trial using
the citric acid or saline solutions (Analysis 2.1).
Catheter blockage/encrustation
In Kennedy 1992, 100 out of the 120 study catheters were ex-
amined for encrustation. The number of catheters found to be
blocked (defined as the eye or lumen completely blocked resulting
in no flow of urine) when removed after each three-week solution
period was reported: saline 18/44 (41%), Suby G 14/29 (48%),
Solution R 7/27 (26%). The authors concluded that Solution R
produced the best results and Suby G the worst, but no statis-
tical tests were presented, and a time effect was noted such that
blocked catheters would be removed early (before they could be
examined) thus distorting these data. Regarding degree of visual
encrustation, Kennedy 1992 reported little difference between the
three solutions up to day 10, after which it was felt Solution R
did not reduce encrustation. Mean encrustation scores were pre-
sented but without standard deviations. Similarly, insufficient in-
formation was presented relating to the mean number of episodes
of bypassing per week (saline 1.55, Suby G 1.4, Solution R 1.9),
although the authors reported that differences between groups on
this outcome were not statistically significant.
Catheter replacement
Kennedy 1992 also reported mean days that the catheter was in
situ: saline 16.3, Suby G 14.3, Solution R 14.2. No standard de-
viations were reported, however the authors reported no signifi-
cant differences between groups. It was noted that only three par-
ticipants retained their catheter for the full length of each trial
period. Moore 2009 reported the mean time until first catheter
change, and as described above there was no significant difference
between the trial groups, including the two groups receiving dif-
ferent washout solutions (citric acid versus saline, Analysis 2.2).
Complications/adverse effects
Blood in the urine
The presence of blood in the urine may be an indication of dam-
age caused as a result of the washout procedure. Kennedy 1992
reported for each group the percentage of participants with red
blood cells in their washout fluid at the end of each treatment
period (saline 21%, Suby G 17%, Solution R 14%). In addition,
the authors reported a significant difference between treatment
groups associated with a higher red blood count in the Suby G
group compared to other groups. Moore 2009 reported results
from urine dipstick testing, and found that all participants, irre-
spective of group, exhibited haematuria consistently.
Urothelial cells in the urine
Presence of urothelial cells in washout fluid at the end of each
treatment period was similarly reported: saline 100%, Suby G
86%, Solution R 100%. Evidence of a significant difference be-
tween treatment groups in presence of urothelial cells over time
was found, however the authors thought this was unlikely to be
clinically significant.
Bladder spasms
Waites 2006 reported on the incidence of bladder spasms di-
rectly attributable to bladder washout, which occurred on a small
number of occasions (saline 0/29, acetic acid 1/30, neomycin-
polymyxin 2/30) and caused these participants to discontinue with
washouts.
Moore 2009 and Waites 2006 reported on the presence of leuko-
cytes and also urine pH. InWaites 2006 pH increased significantly
in all three groups (fromameanof 6.6 at baseline to amean ranging
from 7.0 to 7.2 at eight weeks), but the data were presented graph-
ically and therefore could not be extracted. Waites 2006 found
urinary leukocytes were persistent in all groups throughout the
study, but no comparison between groups was reported and graph-
ical presentation of data precluded data extraction. Moore 2009
reported that mean pH was 6.3 (SD 1.04) and that this did not
change over the study, nor did it correlate with catheter blockage.
Also leukocytes were consistently present in participants’ urine in
the Moore 2009 study.
Resources/costs
No data were reported.
7) A stronger solution of washout versus a weaker
solution
One cross-over trial (Kennedy 1992) compared two acidic solu-
tions with different compositions. The citric acid content of one
solution was higher that the other, however it is noted that the
other elements of the solutions differed also, and therefore any dif-
ferences may not be attributable to the strength of the citric acid.
They concluded that there was no significant difference between
Suby G (containing 3.23% citric acid) and Solution R (containing
6% citric acid) in terms of reducing the level of bacteria in the
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urine, or in the length of time the catheter was in situ. The authors
concluded that Solution R performed better than Suby G in terms
of less blocked catheters (26% versus 48%). As stated previously
the results presented did not utilise the cross-over nature of the
trial and thus were not informative.
No data were reported on any other outcomes of interest
(Bacteriuria; Symptomatic UTI; Catheter blockage/encrustation;
Catheter replacement; Complications/adverse effects; Resources/
costs).
D I S C U S S I O N
The data were insufficient to provide reliable evidence about the
benefit of washout polices in preventing catheter blockage or en-
crustation, or about the relative merits of different washout solu-
tions. Given that it has not been possible to obtain sufficient infor-
mation for further interpretation or analysis of existing published
data from authors of existing trials, further high quality trials must
be recommended to provide rigorous evidence relating to the use
of washouts. There are several important issues raised by this re-
view which have implications for future research in this area.
Summary of main results
This review found a poor evidence base relating to the use of
washouts for long-term indwelling catheters. The evidence con-
sisted of two randomised cross-over trials which had poor data re-
porting, two parallel group randomised controlled trials with very
limited amounts of data, and one well-designed but potentially
under-powered randomised controlled trial. The authors’ conclu-
sions tended to suggest no effect of using washouts, and no bene-
fits of one washout solution over another, in relation to bacteria,
symptomatic UTIs, catheter replacement and blocking/encrusta-
tion. However the quality of trials, their reporting and particularly
their small sample sizes were so poor that it is not appropriate to
draw a conclusion of no effect.
Overall completeness and applicability of
evidence
Types of catheters
Different types of catheter were used across and within trials. It
could be considered pragmatic to allow catheter type to vary in
this way within a trial. However given the apparent difficulty ex-
perienced in recruiting and retaining participants in these trials, it
may be sensible to standardise this variable in future trials to max-
imise the chances of detecting any differences between groups.
Volumes of solutions used for washouts
No trial looked at different volumes of the same washout solu-
tion. Studies tended to use the volume of solution provided in
the manufacturers pre-prepared containers. Volumes ranged from
30 ml (Muncie 1989; Waites 2006) to 100 ml (Kennedy 1992).
Waites 2006 reported that they chose 30 ml after undertaking a
pilot study with 60 ml which resulted in leakage of the washout:
participants in this study had neurogenic bladder and may have
had reduced bladder capacity due to long-term use of indwelling
catheters.
Frequencies of washouts
Neither were there trials comparing different frequencies e.g.
washout once a week versus twice a week. However the frequency
of washout varied across studies: twice daily (Waites 2006), daily
(Muncie 1989; McNicoll 2003), twice weekly (Waites 2006),
weekly (Moore 2009). The length of time the washout was re-
tained in the bladder differed (from 15 minutes (Moore 2009)
through to 20 to 30minutes (Kennedy 1992)), as did the duration
of the intervention (from 3 weeks (Kennedy 1992) to 12 weeks
(McNicoll 2003)).
Treatment-free periods between two arms of
crossover trials
It is important that a “washout period” is used in cross-over trials
where there is potential for a carry-over effect from one treatment
period to the next. Both cross-over trials in this review used this
approach; Muncie 1989 used a two week period between trial
periods with no intervention, whilst Kennedy 1992 used a one
week period during which participants had saline washout. Both
Muncie 1989 and Kennedy 1992 also used run-in periods of two
weeks of no washout and one week of saline washout respectively.
No reason was given for length of the run-in or “washout periods”.
Person performing washout
In all except one trial (Waites 2006) the washout procedure was
undertaken by a health care professional. After the first washout
Waites 2006 gave pre-prepared solutions to the participant to use
at home. This is an interesting, and potentially cost-saving, ap-
proach to catheter care which may be appropriate for certain pa-
tient groups, and could perhaps be the subject of future research.
Participants
The participants included in trials varied in several ways. In some
trials patients had a history of blocked catheters (McNicoll 2003;
Moore 2009) whilst other trials did not limit participation in this
way, or did not mention any history of catheter blocking. There
may be merit in looking specifically at those people with a history
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of blocking since anecdotally it is thought that some individuals
(referred to as “blockers”) are more susceptible than others.
Kennedy 1992 and Muncie 1989 studied inpatient females in
long-term or geriatric care settings who were older (mean age 82
and 71 years respectively) compared to the community-dwelling,
male and female samplewith neurogenic bladder studied byWaites
2006 (mean age 45.8 years). Moore 2009 studied a mix of long-
term care and home care, male and female patients with a mean
age 66 years. No information on age and gender was available for
McNicoll 2003. The effects of a washout, if any, may differ in
such diverse populations and careful thought is needed regarding
whether such trials results could be usefully compared in future
reviews.
Quality of the evidence
Study design
Concealment of group allocation was poor or inadequately de-
scribed in all but one trial (Moore 2009). Similarly, blinding was
not described or was inadequate in all trials, although the difficul-
ties associated with blinding in this type of trial are acknowledged.
Outcomes and analysis
The trials included were somewhat heterogeneous in terms of the
outcomes they measured. Most trials assessed bacteriuria, symp-
tomatic UTIs and blockage/encrustation, although methods for
doing so and definitions used varied. Standardised methods for as-
sessing these key outcomes in catheter research are needed. There
was a consistent lack of adequate reporting of statistical informa-
tion e.g. denominators for percentages, summary statistics such as
standard deviations and details of statistical tests. This made inter-
preting the study results difficult, and extracting the data for tables
of Comparisons and Data impossible in many cases. The meth-
ods used by authors in analysing data from the cross-over trials
were referenced and seemed appropriate, taking into account the
paired nature of the data. However, the reporting of these analyses
within the articles was poor and assessment of the findings and
data extraction were not possible.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is insufficient evidence from randomised controlled trials
to guide clinical practice regarding all aspects of using washouts
for long-term indwelling catheters. Therefore we do not know
whether washouts convey any benefit or harm to patients using
indwelling catheters in the long-term. Neither do we know, there-
fore, whether the associated costs are justified.
Implications for research
Further trials are needed with larger sample sizes and rigorous
methods which will address many questions which are still unan-
swered. Standardisation of outcome measurement is necessary so
that future trials can be compared and combined. Future trials
should include a “no washout” arm as there is first a need for
evidence regarding whether catheter washouts compared to no
washout are beneficial. Other variables that may influence out-
come, and which could be allowed for in the design of future trials,
include baseline characteristics of urine (e.g. acidity), condition of
patient dictating the need for indwelling catheterisation, and the
patient’s fluid intake.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Kennedy 1992
Methods - 3 centre crossover RCT (no mention of blinding)
- 3 interventions: A Sodium chloride washout, B SubyGwashout, C Solution Rwashout
- allocation by random number tables (i.e. to decide order in which 3 solutions admin-
istered)
- intervention duration: 12 weeks (1 week normal saline washout run-in period, 3 x
3 week washout phase with each solution, and 1 week normal saline washout between
interventions)
Participants - 25 elderly females in long-term geriatric care with long-term catheter in-situ
- no exclusion criteria stated
- 25 women entered trial
- 11 women lost to follow up (5 died, 3 catheters removed, 2 withdrawn by nursing staff,
1 discharged)
- 14 women completed full 12 weeks of trial
- 120 catheters inserted during study, 100 examined for encrustation
- mean age 82yrs, range 65-100yrs
- catheter type and material not stated (type patient already wearing used)
- median duration catheter in-situ at start of study: 12 months (range 1-204 months)
Interventions - group A: 3 weeks of twice weekly 0.9% sodium chloride washout
- group B: 3 weeks of twice weekly Suby G washout (citric acid 3.23%, light magnesium
oxide 0.38%, sodium bicarbonate 0.7%, and disodium edetate 0.01%)
- group C: 3 weeks of twice weekly Solution R washout (citric acid 6%, gluconolactone
0.6%, light magnesium carbonate 2.8%, disodium edetate 0.01%)
- each washout administered by attaching 100ml sterile pre-packed sachet to catheter
and allowing to drain into bladder via gravity, clamped for 20-30mins and then allowed
to drain out
- catheters changed at weeks 1, 5, 9 and 12
Outcomes - bacteriuria: patients with bacteria observed in washout fluid at end of washout period:
A 100%, B 75%, C 76% (insufficient data presentation); conclusion was that treatment
with acidic solutions did not prevent or reduce urease-producers
- catheter blockage: blocked catheters: A 18/44, B 14/29, C 7/27, partially blocked
catheters: A 14/44, B 12/29, C 10/27, non-encrusted catheters: A 12/44, B 3/29, C 10/
37 (in each case denominator = no. of catheters)
- degree of visual encrustation: little difference between 3 treatments up to day 10, after
which Solution R did not reduce encrustation (insufficient data presentation)
- mean episodes of bypassing per week: A 1.55, B 1.4, C 1.9 (insufficient data presenta-
tion); differences not statistically significant
- catheter removal/replacement: mean days catheter in situ: A 16.3, B 14.3, C 14.2
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Kennedy 1992 (Continued)
(insufficient data presentation); no significant differences between groups; only 3 patients
retained catheter for full length of each trial period
- patients with red blood cells in washout fluid at end of washout period: A 21%, B
17%, C 14% (insufficient data presentation), higher counts during treatment B
- patients with urothelial cells in washout fluid at end of washout period: A 100%, B
86%, C 100% (insufficient data presentation), some evidence of a significant difference
in the changes over time within the 3 treatments (chi-squared (14) = 22.5, P=0.068) but
proportions all consistently high thus unlikely to be clinically significant
- 1 patient developed haematuria following treatment with solution C
- other outcomes reported (not analysed within this review): type and volume of crystals
observed in washout fluid: significantly more crystals found during saline washouts than
during acidic solutions (chi-square (2) = 29.06, p<0.001); struvite appeared significantly
more often in the saline washouts than in the Suby G and Solution R washouts (chi-
square (2) = 22.075, p<0.001); uric acid crystals appeared with Suby G and Solution
R; calcium oxalate was slightly more common in saline washouts than during the acidic
treatments; urates were seen only during saline washouts; no difference between the 3
regimes at the end of each 3-week washout period
- white blood cells present in washout fluid: A 100%, B 87%, C 14% (insufficient data
presentation); no significant differences between the 3 treatments
Notes - definition of blocked catheter: eyes or lumen completely blocked, resulting in no flow
of urine
- definition of partially blocked catheter: still able to allow urine drainage
- analysis based on end-point data available
- insufficient data to analyse any possible interactions involving treatment order
- authors’ conclusion: acidic washouts administered twice weekly for 3 weeks had no
effect on preventing crystal formation or catheter encrustation, and the frequency of red
cells in the urine suggests an adverse effect on the bladder endothelium
Risk of bias Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Yes Adequate (random number tables used to
determine the order of the solutions)
Allocation concealment? No Inadequate (procedure not described)
Blinding?
All outcomes
Unclear No mention of blinding
Incomplete outcome data addressed?
All outcomes
Yes States numbers and reasons
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McNicoll 2003
Methods - single centre parallel group RCT (no mention of blinding)
- 2 groups: A citric acid catheter maintenance solutions (CMS’), B planned catheter
changes
- method of group allocation not stated
Participants - 11 community patients with long term catheters known to block with encrustation
- no exclusion criteria stated
- 11 participants enrolled in trial (number allocated to each group not stated)
- 7 participants lost to follow-up (reasons not stated)
- 4 patients analysed (A 1, B 3)
- age and sex of participants not stated
- urethral catheters, material not stated
- duration catheter in situ at start of study not stated
Interventions - group A: daily instillation of citric acid CMS’, volume used and method of adminis-
tration not stated (108 patient contacts)
- group B: planned catheter removal (approx. 55 patient contacts)
- duration of intervention was 12 weeks
Outcomes - catheter replacements: group A mean 9 (SD 0) (n=1), group B mean14.3 (SD 11.2)
(n=3)
- resources: time to implement intervention, group A mean 37.25 hours (SD 0) (n=1),
group B not reported (insufficient data presentation)
- cost of intervention: group A mean £975.51 (SD 0) (n=0), group B mean £188.70
(SD £102.90) (n=3)
Notes - planned catheter change intervention varied: 1 patient had catheter changed twice a
week, 1 patient had catheter changed when it showed signs of blocking, 1 patient had
weekly pH tests and had catheter changed at beginning and end of the study
- nursing care provided by district nurses
- analysis based on end point data available
- author’s conclusion: method B utilised less in terms of time, cost and reduced risk of
infection compared with method A however complete data on time and risk of infection
not reported
Risk of bias Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Unclear
Allocation concealment? Unclear Unclear
Blinding?
All outcomes
Unclear No mention of blinding
Incomplete outcome data addressed?
All outcomes
Yes States numbers only (no reason given)
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Moore 2009
Methods - parallel group RCT
- 3 groups: catheter flush with saline vs acidic solution vs standard care (no washout)
- attempts to blind patients, research nurses were not blinded to solution
Participants - community dwelling or longterm care
- English speaking individuals
- MMSE >=23
- indwelling catheter in situ longer than 30 days andwho require catheter changes because
of blockage more than once a month
- exclusion criteria included: symptomatic UTI (individuals were eligible for the study
following successful treatment of the UTI after
a symptom-free period of 14 days); urethral erosion allowing continuous bypassing
(leakage) around urinary catheter; history of bladder cancer, or radiation or interstitial
cystitis; impaired renal function as evidenced by a serum creatinine level of 2.0 mg/dL
or higher; gross hematuria; or indwelling catheter that was changed less frequently than
every 8 weeks
Interventions - group A: 8 weeks of usual care, no washout (control)
- group B: 8 weeks of weekly washout with 50 ml sterile normal saline washout
- group C: 8 weeks of weekly washout with 50 ml sterile Contisol solution (containing
citric acid 3.23%, light magnesium oxide 0.38%, sodium bicarbonate 0.7%, and dis-
odium edetate 0.01%)
Outcomes - mean time to first catheter change: Contisol 4.57 (SD 2.61) (n=19), saline 5.18 (SD
2.90) (n=16), no washout 4.55 (SD 2.91) (n=20)
- incidence of symptomatic UTI (defined as at least one of five indications with no
other recognised cause: fever >=38 degrees C, urgency, dysuria or suprapubic tenderness,
haematuria or positive urine culture (>=100,000 microorganisms per cc of urine with no
more than two species of microorganisms). None were detected in any group: Contisol
0/17, saline 0/16, control 0/20.
- incidence of microscopic haematuria. All participants had haematuria consistently (no
data provided).
- incidence of microscopic leukocytes. All participants had haematuria consistently (no
data provided).
- urine pH: mean pH 6.3 (SD 1.04) (range 5-8.5), not reported for groups
- measurement of cross sectional catheter lumen. slicing of first 50 catheters supported
the theory that biofilm or encrustations begins at the catheter tip, first at the eyes,
proceeding down the shaft. % of catheters with encrustation was low and the majority
were obstructed with thick biofilm
Notes - cross sectional measurement of catheter was abandoned as the method did not prove
useful for comparing effectiveness of washouts
- data on all available patients was included in the Kaplan Meier analysis of time to first
catheter change (with censoring when an individual withdrew, died, had a UTI treated
with antibiotics, etc), however results on mean time to first catheter change are based on
data for those who completed the trial only
- authors gave reviewers access to data for further analysis
Risk of bias Risk of bias
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Moore 2009 (Continued)
Item Authors’ judgement Description
Adequate sequence generation? Yes Adequate (computer generated random
numbers)
Allocation concealment? Yes Adequate (group allocation placed in
opaque envelope, opened by participant)
Blinding?
All outcomes
Yes Blinding stated but no description given
(blinding of the participants to washout
type attempted, not possible to blind the
research nurse due to nature of the inter-
vention and the packaging of washouts)
Incomplete outcome data addressed?
All outcomes
Yes States numbers and reasons
Muncie 1989
Methods - single centre crossover RCT (no mention of blinding)
- 2 interventions: group A normal saline irrigation, group B no irrigation
- method of group allocation not stated
- intervention duration: 24 weeks (2-week no irrigation run-in period, 2 x 10 week
irrigation/no irrigation phase, and 2 week no-irrigation washout period before entering
alternate phase)
Participants - 44 long-term hospitalised female patients
- aged 18 years or more, mean age 71 years, range 37 to 88 years, 33 women were aged
65 or over
- with indwelling urethral catheters in place for 30 consecutive days or longer
- were afebrile (temperature <= 37.7 degrees) for 7 days
- had not received antibiotics for 14 days
- excluded: patients with malignant bladder neoplasms or patients whose physician
insisted on continued bladder irrigation
- 44 women entered the trial, 21 women did not complete the full intervention (10 died,
4 discharged, 3 catheter removed, 4 physician request), 23 women completed the full
24 week intervention (A first 10, B first 13), 9 women completed at least one phase and
five weeks of the second phase of the study
- 32 women analysed: 23 crossovers, 9 partial crossovers
- catheter type: double lumen, 18 F, silicone-coated latex urethral catheters
- mean hospital stay longer for those who completed the study (810 days) than for those
who did not (455 days) (p<0.05)
- neither age nor activities of living distinguished between those who completed the
study and those who did not
Interventions - group A: 10 weeks of once daily normal saline irrigation (30mls via bladder syringe)
- group B: 10 weeks of no irrigation
- new catheters inserted at beginning and end of each study phase, drainage bags changed
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Muncie 1989 (Continued)
weekly in both groups
- drainage bags with built-in irrigation ports used that enabled irrigation without dis-
ruption of the closed catheter system
Outcomes Patients who completed (n=23)
- bacteriuria: mean number of species (at >=10 to power 5) per urine specimen: group A
4.0, group B 3.8. No standard deviations reported. 4 most prevalent organisms in each
phase: Providencia stuartii, Escherichia coli, P mirabilis and enterococcus; percentage of
specimens in which each present was similar in each phase.
- febrile episodes: mean number of febrile episodes of possible urinary origin
1st period: irrigation 1.6 (SD 1.7) (n=10), non-irrigation 0.9 (SD 1.1) (n=13)
2nd period: irrigation 1.0 (SD 1.6) (n=13), non-irrigation 0.6 (SD 0.7) (n=10)
All participants (n=32)
- febrile episodes of possible urinary origin per 100 days of catheterisation: group A
mean1.2 (SD 1.3) (n=32), group B mean 0.9 (SD 1.1) (n=32)
- catheter replacements per 100 days of catheterisation: group A mean 5.5 (SD not
reported) (n=32), group B mean 4.7 (SD not reported) (n=32)
- no. of catheter replacements due to obstruction (n=32): A 39, B 32; no. of catheter
replacements due to leakage (n=32): A 11, B 21; no. of non-prescribed catheter removals
(n=32): A 87, B 63
- other outcomes reported (not analysed within this review): all febrile episodes per 100
days of catheterisation: group A mean 1.7 (SD 1.9) (n=32), group B mean 1.1 (SD 1.6)
(n=32)
Notes - definition of febrile episode: consecutive days of fever (temperature more than 37.7
degrees) classified using predefined criteria of 44 diagnosis of infection and other causes
of fever. If not thought to be from any of these then classed as of possible urinary origin.
- definition of catheter leakage: patient’s bed being wet with urine with the catheter still
connected to the connection tube
- definition of catheter obstruction: absence of urine flow from the catheter that irrigation
could not restore
- daily irrigations administered by trained nurse
- routine catheter care included daily perineal cleansing with soap and water
- number of non-protocol irrigations were similar during irrigation and non-irrigation
periods
- analysis based on end point data available
- 2 sets of analysis carried out: patients completing all 24 weeks of the study, patients
who completed one period and at least 5 weeks of the next period
- authors’ conclusion: Routine, once daily normal saline irrigation of long-term in-
dwelling urethral catheters does not reduce the incidence of catheter obstructions or
episodes of fever
Risk of bias Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Unclear
Allocation concealment? Unclear Unclear
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Unclear No mention of blinding
Incomplete outcome data addressed?
All outcomes
Yes States numbers and reasons
Waites 2006
Methods - parallel group RCT (double blind but no description given)
- 3 groups: group A normal saline irrigation, B acetic acid irrigation, C neomycin-
polymyxin GU irrigation
- groups stratified by sex
- method of group allocation not stated
- intervention duration: 8 weeks
Participants - 89 community residing patients with neurogenic bladder managed by indwelling
catheter
- at least 6 months post spinal cord injury or onset of other neurological disease
- evidence of microscopic bacteriuria and pyuria at time of study enrolment
- excluded: patients with serious UTIs requiring systemic antibiotics or with prior renal
function abnormalities, patients who had used an acidifying agent, bladder irrigant or
systematic antibiotic in previous 7 days, and patients who were pregnant or unable/
unwilling to give informed consent
- 89 participants entered the trial (group A 29, group B 30, group C 30)
- 37 participants did not complete the full intervention (11withdrewdue to development
of symptomatic UTI, 14 withdrew due to other health related reasons, 12 withdrew due
to perceived difficulty, inconvenience or unwillingness to perform twice daily irrigations)
- 52 participants completed the intervention and were analysed (group A 21, group B
9, group C 22)
- no differences in demographic and injury related variables by group at baseline
- years since injury or onset of disease significantly greater for participants who did not
complete the study protocol
- mean age 45.8 years, range 19 to 82 years
- 49 men, 40 women
- catheter type 71 foley catheter, 18 suprapubic tube, catheter material not stated
- duration catheter in situ pre-study enrolment not stated
Interventions - group A: 8 weeks of twice daily normal saline irrigation
- group B: 8 weeks of twice daily 0.25% acetic acid irrigation
- group C: 8 weeks of twice daily neomycin-polymyxin GU irrigation containing 40mg/
ml neomycin sulfate and 200,000 units/ml polymyxin B
- 30 mls of each irrigant instilled for 20mins via bladder syringe
Outcomes - bacteriuria or pyuria in urine: no data reported at group level except for Enterococcus
species (see below)
- participants harbouring Enterococcus species alone or in conjunction with other types
of bacteria after completing study: group A: 13/21, group B: 7/9, group C: 19/22
- increased occurrence of enterococci over time significant for group C (p=0.02) (data
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Waites 2006 (Continued)
reported graphically hence unable to determine exact values by group)
- participants discontinuing use of irrigation due to development of symptomatic UTI:
group A: 1/29, group B: 6/30, group C: 4/30
- acceptability: bladder irrigation well tolerated with the exception of 3 participants (see
adverse effects)
- adverse effects: bladder spasms attributed directly to participation in bladder irrigation:
group A 0/29, group B 1/30, group C 2/30
- other outcomes reported (not analysed within this review): generation of antimicrobial-
resistant organisms, urinary pH, urinary leukocytes
Notes - first irrigation shown to patient in clinic setting, remaining irrigations administered at
home by participant or carer
- participants advised to continue usual practices for perineal hygiene and catheter care
- drop out rate in group B significantly higher than other two groups
- analysis based on end point data available
- data analysis combines patients with urethral and suprapubic catheters (author con-
tacted to request results separately for these groups however with no success)
- authors’ conclusion: no basis on which to recommend the use of bladder irrigation
as a routine method for treating asymptomatic bacteriuria in catheterised people with
neurogenic bladder
Risk of bias Risk of bias
Item Authors’ judgement Description
Adequate sequence generation? Unclear Unclear
Allocation concealment? Unclear Unclear
Blinding?
All outcomes
Yes Blinding stated but no description given
(participants and healthcare providers
blinded, no mention of blinding of out-
come assessor)
Incomplete outcome data addressed?
All outcomes
Yes States numbers and reasons
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Andersson 1986 Primary outcomes of interest to review (i.e. catheter-associated infection and encrustation) not addressed.
RCT of Varidase versus saline to compare effects and side effects in patients with catheter problems. Outcomes
studied related to cleansing of bladder from pus, fibrin, necrotic tissue and blood clots
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Bach 1990 Not long term catheterisation.
RCT of citric acid versus saline to prevent catheter encrustation
Bruun 1978 Unable to determine duration of catheterisation.
RCT (crossover design) of four irrigating solutions: saline, 0.25% acetic acid, 0.02% chlorhexidine, 0.25% silver
nitrate
Davies 1987 Not all patients catheterised for more than 28 days.
RCT of chlorhexidine versus saline on urinary bacterial count. 48 patients catheterised for 3 weeks or more
Elliott 1989 Study methods insufficiently described and insufficient data reported on the effect on bacteruria in treatment and
control groups. Thus the study was excluded as it did not contribute information on any of the reviews primary
outcome measures, rather it focused on urothelial exfoliations rates and presented these data only graphically
RCT (crossover design) of effect of washouts (2.5% noxythiolin or saline) on the urothelium
Elliott 1990 Unable to determine if patients randomised. Study methods insufficiently described. Insufficient data reported
for calculating the effect on bacteruria in treatment and control groups
Furuno 1998 Not an RCT.
Comparison of irrigation with super oxidation water and normal saline in 21 paraplegics (conference abstract at
33rd Annual Meeting of Japan Medical Society of Paraplgia 1998)
Gelman 1980 Unable to determine if patients randomised. Duration of catheterisation at start of study less than 28 days for
some patients.
Comparison of three methods of irrigation with 0.25% acetic acid (no irrigation, one irrigation a week, two
irrigations per day)
Kennedy 1984 Not an RCT.
Crossover study of saline versus two Uro-tainer solutions.
Meyers 1964 Not all patients catheterised for more than 28 days. Analysis of long-term catheterised patients not reported.
RCT of nitrofurazone and neomycin/polymyxin for prevention of bacteriuria
Robertson 1990 Not an RCT.
Comparison of effect of mandelic acid on two different types of species. There was only a single group of subjects
who received a single regimen of 1% mandelic acid
Ruwaldt 1983 Unable to determine if RCT.
Crossover comparison of twice daily irrigations with Suby G versus no irrigations
Vainrub 1977 Comparison with intermittent catheterised patients not relevant to review.
Comparison of effect of methanamine mandelate and ascorbic acid on bacteriuria between indwelling and inter-
mittent catheterised patients
Warren 1978 Not long term catheterisation.
RCT of neomycin-polymyxin irrigation versus no irrigation for prevention of UTIs
25Washout policies in long-term indwelling urinary catheterisation in adults (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of studies awaiting assessment [ordered by study ID]
Airaksinen 1979
Methods - RCT with 4 groups. The study set out to compare 2 different types of catheter and also two different washouts.
Also aimed to assess the effect of the balloon size
Participants - 40 participants (10 per group) who were 18 years or older. 5 were home-dwelling, the remainder were in hospital
Interventions - Saline washout versus no washout
Outcomes - Effect of irrigation on catheter function and UTIs.
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Any washout vs no washout




participants Statistical method Effect size
1 no. of people with symptomatic
UTI
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 any washout versus no
washout
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 saline washout versus no
washout
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 citric acid washout versus
no washout
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 weeks to first catheter change 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 any washout versus no
washout
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.2 saline washout versus no
washout
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.3 citric acid washout versus
no washout
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Comparison 2. One washout solution versus another




participants Statistical method Effect size
1 no. of people with symptomatic
UTI
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 citric acid verus saline 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2 weeks to first catheter change 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 citric acid verus saline 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
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Analysis 1.1. Comparison 1 Any washout vs no washout, Outcome 1 no. of people with symptomatic UTI.
Review: Washout policies in long-term indwelling urinary catheterisation in adults
Comparison: 1 Any washout vs no washout
Outcome: 1 no. of people with symptomatic UTI
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 any washout versus no washout
Moore 2009 0/33 0/20 Not estimable
2 saline washout versus no washout
Moore 2009 0/16 0/20 Not estimable
3 citric acid washout versus no washout
Moore 2009 0/17 0/20 Not estimable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.2. Comparison 1 Any washout vs no washout, Outcome 2 weeks to first catheter change.
Review: Washout policies in long-term indwelling urinary catheterisation in adults
Comparison: 1 Any washout vs no washout
Outcome: 2 weeks to first catheter change





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 any washout versus no washout
Moore 2009 35 4.86 (2.72) 20 4.55 (2.91) 0.31 [ -1.25, 1.87 ]
2 saline washout versus no washout
Moore 2009 16 5.18 (2.9) 20 4.55 (2.91) 0.63 [ -1.28, 2.54 ]
3 citric acid washout versus no washout
Moore 2009 19 4.57 (2.61) 20 4.55 (2.91) 0.02 [ -1.71, 1.75 ]
-10 -5 0 5 10
Favours control Favours treatment
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Analysis 2.1. Comparison 2 One washout solution versus another, Outcome 1 no. of people with
symptomatic UTI.
Review: Washout policies in long-term indwelling urinary catheterisation in adults
Comparison: 2 One washout solution versus another
Outcome: 1 no. of people with symptomatic UTI
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 citric acid verus saline
Moore 2009 0/17 0/16 Not estimable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 2.2. Comparison 2 One washout solution versus another, Outcome 2 weeks to first catheter
change.
Review: Washout policies in long-term indwelling urinary catheterisation in adults
Comparison: 2 One washout solution versus another
Outcome: 2 weeks to first catheter change





N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 citric acid verus saline
Moore 2009 19 4.58 (2.61) 16 5.19 (2.9) -0.61 [ -2.45, 1.23 ]
-10 -5 0 5 10
Favours control Favours treatment
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A P P E N D I C E S
Appendix 1. Search strategies used for this review
We searched:
• MEDLINE (January 1966 to April 2009),
• MEDLINE In-Process (searched on 30 April 2009),
• EMBASE (January 1980 to Week 17 2009) was searched on 27 April 2009,
• CINAHL on OVID (1982 to July Week 1 2007) was searched on 18 July 2007,
• CINAHL on EBSCO (December 1981 to Week 4 April 2009) was searched on 28 April 2009.
These databaseswere searchedby the review authors using appropriate free text andMeSHterms/EMTREE terms/controlled vocabulary.
This was done by adapting terms drawn from the existing search strategies of the Incontinence Review Group to meet the objectives
of this review. Full details of the search terms used are given below:
MEDLINE and MEDLINE In-Process & Other Non-Indexed Citations on OVID
1. Irrigation/
2. (bladder adj5 irrigat$).mp. [mp=title, original title, abstract, name of substance word, subject heading word]
3. bladder washout$.mp.
4. (catheter$ adj5 irrigat$).mp. [mp=title, original title, abstract, name of substance word, subject heading word]




9. Anti-Bacterial Agents/ad, tu [Administration & Dosage, Therapeutic Use]
10. Anti-Infective Agents/ad, tu [Administration & Dosage, Therapeutic Use]
11. Antifungal Agents/ad, tu [Administration & Dosage, Therapeutic Use]
12. Candidiasis/dt [Drug Therapy]
13. Bacteriuria/dt [Drug Therapy]
14. Bacteriuria/pc [Prevention & Control]
15. or/1-14
16. catheters, Indwelling/
17. urinary catheter$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
18. Urinary Catheterization/
19. ((long-term or long-term or longterm) adj2 catheter$).mp. [mp=title, original title, abstract, name of substance word, subject
heading word]




24. Catheterization, Central Venous/
25. Postoperative Care/
26. Vascular Patency/
27. 24 or 25 or 26
28. 15 and 23
29. 28 not 27
This set of terms was combined with the first two parts of the Cochrane Highly Sensitive Search Strategy for identifying reports of
randomised controlled trials in MEDLINE (Appendix 5b.2, Cochrane Reviewers Handbook, version 4.2, March 2003) using the
Boolean operator ’AND’.
CINAHL (on OVID)
1. “URINARY CATHETER IRRIGATION (SABA CCC)”/ or CATHETER IRRIGATION, URINARY/ or URINARY BLADDER
IRRIGATION/ or irrigation.mp. or IRRIGATION/
30Washout policies in long-term indwelling urinary catheterisation in adults (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2. (catheter$ adj3 maintenanc$).mp. [mp=title, subject heading word, abstract, instrumentation]
3. catheter blockage$.mp.
4. encrustation$.mp. or Catheter Occlusion/
5. Antiinfective Agents/ad, tu [Administration and Dosage, Therapeutic use]
6. Antifungal Agents/ad, tu [Administration and Dosage, Therapeutic use]
7. CANDIDIASIS/dt [Drug Therapy]
8. BACTERIURIA/pc, dt [Prevention and Control, Drug Therapy]
9. Catheter-Related Infections/pc, dt [Prevention and Control, Drug Therapy]
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11. urinary catheterization.mp.
12. urinary catheterisation.mp. or Urinary Catheterization/
13. urinary catheter$.mp. or Catheters, Urinary/
14. Catheter Care, Urinary/
15. (long-term adj2 catheter$).mp.
16. bladder catheter$.mp.
17. urethral catheter$.mp.
18. 11 or 12 or 13 or 14 or 15 or 16 or 17
19. 10 and 18
This set of terms was combined with the sensitive search strategy for identifying reports of trials in CINAHL (developed by theCochrane
Stroke Group, available via OVID on the NHS eLibrary) using the Boolean operator ’AND’.
CINAHL (on EBSCO)
# Query
S53 S52 and em 200707-
S52 S27 and S51
S51 S40 and S50
S50 S41 or S42 or S43 or S44 or S45 or S46 or S47 or S48 or S49
S49 urethral catheter*
S48 bladder catheter*
S47 (long-term or longterm) N2 catheter*
S46 (MH “Catheter Care, Urinary”)
S45 (MH “Catheters, Urinary”)
S44 urinary catheter*
S43 (MH “Urinary Catheterization”)
S42 urinary catheterisation
S41 urinary catheterization
S40 S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39
S39 (MH “Catheter-Related Infections/DT/PC”)
S38 (MH “Bacteriuria/DT/PC”)
S37 (MH “Candidiasis/DT”)
S36 (MH “Antifungal Agents/AD/TU”)
S35 (MH “Antiinfective Agents/AD/TU”)
S34 encrustation*
S33 catheter* N3 blockage*
S32 catheter* N3 maintenanc*
S31 TI irrigation or AB irrigation
S30 (MH “Catheter Occlusion”)
S29 (MH “Irrigation”) or (MH “Urinary Bladder Irrigation”)
S28 (MH “Catheter Irrigation, Urinary”) or (MH “Urinary Catheter Irrigation (Saba CCC)”)
S27 S26 or S25
S26 (MH “Comparative Studies”)
S25 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20
or S21 or S22 or S23 or S24
S24 (MH “Clinical Research+”)
31Washout policies in long-term indwelling urinary catheterisation in adults (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S23 (MH “Static Group Comparison”)
S22 (MH “Quantitative Studies”)
S21 (MH “Crossover Design”) or (MH “Solomon Four-Group Design”)
S20 (MH “Factorial Design”)
S19 (MH “Community Trials”)
S18 (MH “Random Sample”)
S17 (MH “Random Assignment”)
S16 TI balance* N2 block* or AB balance* N2 block*
S15 TI “latin square” or AB “latin square”
S14 TI cross-over or AB cross-over
S13 TI crossover or AB crossover
S12 TI factorial or AB factorial
S11 TI ( tripl* N25 (blind* or mask*) ) or AB ( tripl* N25 (blind* or mask*) )
S10 TI ( trebl* N25 (blind* or mask*) ) or AB ( trebl* N25 (blind* or mask*) )
S9 TI ( doubl* N25 (blind* or mask*) ) or AB ( doubl* N25 (blind* or mask*) )
S8 TI ( singl* N25 (blind* or mask*) ) or AB ( singl* N25 (blind* or mask*) )
S7 TI clin* N25 trial* or AB clin* N25 trial*
S6 (MH “Study Design”)
S5 (AB random*) OR (TI random*)
S4 (AB placebo*) OR (TI placebo*)
S3 (MH “Placebos”)
S2 PT Clinical Trial
S1 (MH “Clinical Trials+”)
EMBASE on OVID
1. irrigation.mp. or BLADDER IRRIGATION/
2. (catheter$ adj3 maintenanc$).mp. [mp=title, subject heading word, abstract, instrumentation]
3. bladder washout$.mp.
4. catheter blockage$.mp.
5. encrustation$.mp. or Catheter Occlusion/
6. Crystallization/
7. Antiinfective Agent/ad, do, dt [Drug Administration, Drug Dose, Drug Therapy]
8. Antifungal Agent/ad, do, dt [Drug Administration, Drug Dose, Drug Therapy]
9. antibacterial agent$.mp.
10. CANDIDIASIS/dm, dt, th [Disease Management, Drug Therapy, Therapy]
11. BACTERIURIA/pc, dm, dt, th [Prevention, Disease Management, Drug Therapy, Therapy]
12. Catheter Infection/pc, dm, dt, th [Prevention, Disease Management, Drug Therapy, Therapy]








21. suprapubic bladder catheterization/




26. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25
27. 13 and 26
28. Postoperative Care/
29. Vascular Patency/
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30. Central Venous Catheterization/
31. 28 or 29 or 30
32. 27 not 31
This set of terms was combined with the Cochrane suggested search strategy for identifying reports of randomised controlled trials in
EMBASE (available via OVID on the NHS eLibrary) using the Boolean operator ’AND’. An optimal strategy for EMBASE has not
yet been tested and formally approved. However, the suggested strategy has been employed in searches for the Cochrane collaboration.
The UK National Research Register, Controlled Clinical Trials and ZETOC database of conference abstracts were searched on 17
October 2006 using various combinations of the following search terms: catheter, bladder, washout, maintenance, solution, irrigation,
instillation, care, infection, bacteriuria, encrustation, blockage, occlusion, crystallisation, anti-infective agents, anti-bacterial agents.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
No major alterations were made to the protocol during the completion of the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Catheters, Indwelling; Device Removal; Equipment Failure; Randomized Controlled Trials as Topic; Solutions [∗administration &
dosage; chemistry]; Therapeutic Irrigation [adverse effects; ∗methods]; Time Factors; Urinary Bladder Neck Obstruction [therapy];
Urinary Catheterization [∗instrumentation]; Urinary Incontinence [therapy]
MeSH check words
Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged
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